Published in Eur J Nucl Med Mol Imaging on July 21, 2006
SPECT imaging evaluation in movement disorders: far beyond visual assessment. Eur J Nucl Med Mol Imaging (2010) 1.71
Comparison between Different Intensity Normalization Methods in 123I-Ioflupane Imaging for the Automatic Detection of Parkinsonism. PLoS One (2015) 1.44
European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. Eur J Nucl Med Mol Imaging (2012) 1.19
Calibration of gamma camera systems for a multicentre European ¹²³I-FP-CIT SPECT normal database. Eur J Nucl Med Mol Imaging (2011) 0.93
Improving quantitative dosimetry in (177)Lu-DOTATATE SPECT by energy window-based scatter corrections. Nucl Med Commun (2014) 0.92
Combined visual and semi-quantitative assessment of (123)I-FP-CIT SPECT for the diagnosis of dopaminergic neurodegenerative diseases. Neurol Sci (2017) 0.84
Is absolute quantification of dopaminergic neurotransmission studies with 123I SPECT ready for clinical use? Eur J Nucl Med Mol Imaging (2008) 0.83
Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease. Eur J Nucl Med Mol Imaging (2015) 0.82
Reduction in camera-specific variability in [(123)I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls. Eur J Nucl Med Mol Imaging (2016) 0.82
Feasibility of PET Template-Based Analysis on F-18 FP-CIT PET in Patients with De Novo Parkinson's Disease. Nucl Med Mol Imaging (2013) 0.81
Quantification of dopaminergic neurotransmission SPECT studies with 123I-labelled radioligands. A comparison between different imaging systems and data acquisition protocols using Monte Carlo simulation. Eur J Nucl Med Mol Imaging (2008) 0.80
The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [(123)I]FP-CIT SPECT imaging. EJNMMI Res (2017) 0.79
Fully Automated Quantification of the Striatal Uptake Ratio of [(99m)Tc]-TRODAT with SPECT Imaging: Evaluation of the Diagnostic Performance in Parkinson's Disease and the Temporal Regression of Striatal Tracer Uptake. Biomed Res Int (2015) 0.78
Experimental determination of the weighting factor for the energy window subtraction-based downscatter correction for I-123 in brain SPECT studies. J Med Phys (2010) 0.77
Multipinhole collimator with 20 apertures for a brain SPECT application. Med Phys (2014) 0.77
(123)I-Meta-iodobenzylguanidine Sympathetic Imaging: Standardization and Application to Neurological Diseases. Chonnam Med J (2016) 0.75
Comment on Mertens et al.: Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases. Eur J Nucl Med Mol Imaging (2013) 0.75
Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson's Disease. Neurol Med Chir (Tokyo) (2016) 0.75
CADA-computer-aided DaTSCAN analysis. EJNMMI Phys (2016) 0.75
Imaging analysis of Parkinson's disease patients using SPECT and tractography. Sci Rep (2016) 0.75
The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes. Nucl Med Commun (2017) 0.75
Reduced 123I Ioflupane Binding in Bilateral Diabetic Chorea: Findings With 18F FDG PET, 99mTc ECD SPECT, and 123I MIBG Scintigraphy. Clin Nucl Med (2016) 0.75
Multivariate Analysis of (18)F-DMFP PET Data to Assist the Diagnosis of Parkinsonism. Front Neuroinform (2017) 0.75
Dysfunctional counting of mental time in Parkinson's disease. Sci Rep (2016) 0.75
Optimal ROI setting on the anatomically normalized I-123 FP-CIT images using high-resolution SPECT. Ann Nucl Med (2016) 0.75
[(123)I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods. EJNMMI Phys (2017) 0.75
Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosomes versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study. Neuroradiology (2016) 0.75
Early-onset parkinsonism in a pedigree with phosphoglycerate kinase deficiency and a heterozygous carrier: do PGK-1 mutations contribute to vulnerability to parkinsonism? NPJ Parkinsons Dis (2017) 0.75
(123)I-FP-CIT SPECT findings and its clinical relevance in prodromal dementia with Lewy bodies. Eur J Nucl Med Mol Imaging (2016) 0.75
Computed-tomography-guided anatomic standardization for quantitative assessment of dopamine transporter SPECT. Eur J Nucl Med Mol Imaging (2016) 0.75
Refining diagnosis of Parkinson's disease with deep learning-based interpretation of dopamine transporter imaging. Neuroimage Clin (2017) 0.75
Correlations between dopamine transporter density measured by (123)I-FP-CIT SPECT and regional gray matter volume in Parkinson's disease. Jpn J Radiol (2017) 0.75
Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 211.50
Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA (2002) 3.46
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord (2000) 2.10
Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT. J Nucl Med (1995) 1.77
[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 1.51
Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol (2004) 1.33
Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry (2002) 1.28
[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease. Neurology (1996) 1.24
Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients. J Nucl Med (1998) 1.22
Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease. J Nucl Med (1998) 1.22
Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab (1994) 1.21
Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging. J Nucl Med (2000) 1.07
[123I]beta-CIT and SPECT in essential tremor and Parkinson's disease. J Neural Transm (Vienna) (1998) 1.07
Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease. Eur J Nucl Med (1997) 1.04
Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers. J Nucl Med (2000) 1.01
Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. J Neural Transm Suppl (1997) 1.01
One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT. J Nucl Med (1999) 1.00
[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Mov Disord (2000) 0.98
Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography. Eur J Nucl Med (1997) 0.95
Contribution of scatter and attenuation compensation to SPECT images of nonuniformly distributed brain activities. J Nucl Med (2003) 0.91
Reproducibility of dopamine transporter density measured with 123I-FPCIT SPECT in normal control and Parkinson's disease patients. Ann Nucl Med (2004) 0.88
Age-related changes in D2 receptor binding with iodine-123-iodobenzofuran SPECT. J Nucl Med (1998) 0.88
Simplified quantification of dopamine transporters in humans using [99mTc]TRODAT-1 and single-photon emission tomography. Eur J Nucl Med (2000) 0.88
Loss of dopamine transporter binding in Parkinson's disease follows a single exponential rather than linear decline. J Nucl Med (2004) 0.87
Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters. J Nucl Med (1996) 0.87
Basal ganglia volume in adults with Down syndrome. Psychiatry Res (1997) 0.86
Investigating dopaminergic neurotransmission with 123I-FP-CIT SPECT: comparability of modern SPECT systems. J Nucl Med (2003) 0.85
The specific uptake size index for quantifying radiopharmaceutical uptake. Phys Med Biol (2004) 0.82
Comparison of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain. Eur J Nucl Med (1995) 0.81
Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease. Eur J Nucl Med (2001) 0.80
Absolute quantification in dopaminergic neurotransmission SPECT using a Monte Carlo-based scatter correction and fully 3-dimensional reconstruction. J Nucl Med (2005) 0.78
Influence of collimator characteristics on quantification in SPECT. J Nucl Med (1996) 0.78
Effects of scatter and attenuation correction on quantitative analysis of beta-CIT brain SPET. Nucl Med Commun (1999) 0.77
[123I]IPT binding to the presynaptic dopamine transporter: variation of intra- and interobserver data evaluation in parkinsonian patients and controls. Eur J Nucl Med (2000) 0.76
UK audit of left ventricular ejection fraction estimation from equilibrium ECG gated blood pool images. Nucl Med Commun (2005) 1.55
Dynamic left ventricular obstruction: a potential cause of angina in end stage renal disease. Int J Cardiol (2005) 1.52
Correction of the slope-intercept method for the measurement of glomerular filtration rate. Nucl Med Commun (2014) 1.48
The prevalence and nature of prescribing and monitoring errors in English general practice: a retrospective case note review. Br J Gen Pract (2013) 1.38
The new BNMS guidelines for measurement of glomerular filtration rate. Nucl Med Commun (2004) 1.17
Mitral annular calcification predicts mortality and coronary artery disease in end stage renal disease. Atherosclerosis (2006) 1.15
Measuring glomerular filtration rate using chromium-51 EDTA: body surface area normalization before or after Brøchner-Mortensen correction? Nucl Med Commun (2015) 1.09
Ischemia-modified albumin predicts mortality in ESRD. Am J Kidney Dis (2006) 1.01
Mitral peak Doppler E-wave to peak mitral annulus velocity ratio is an accurate estimate of left ventricular filling pressure and predicts mortality in end-stage renal disease. J Am Soc Echocardiogr (2006) 1.01
A prospective randomized study to evaluate stress response during beating-heart and conventional coronary revascularization. Ann Thorac Surg (2004) 0.97
Limitations of the HMPAO SPECT appearances of occipital lobe perfusion in the differential diagnosis of dementia with Lewy bodies. Nucl Med Commun (2007) 0.88
Measurement of fracture kyphosis with the Oxford Cobbometer: intra- and interobserver reliabilities and comparison with other techniques. Spine (Phila Pa 1976) (2005) 0.86
Echocardiography-based score to predict outcome after renal transplantation. Heart (2006) 0.85
A spatial model of the human airway tree: the hybrid conceptual model. J Aerosol Med Pulm Drug Deliv (2010) 0.84
The specific uptake size index for quantifying radiopharmaceutical uptake. Phys Med Biol (2004) 0.82
The role of drains and tourniquets in primary total knee replacement: a comparative study of TKR performed with drains and tourniquet versus no drains and adrenaline and saline infiltration. J Knee Surg (2004) 0.81
Predicting the outcome of Legg-Calve-Perthes' disease in children under 6 years old. J Child Orthop (2007) 0.81
Evaluation of ischaemia-modified albumin as a marker of myocardial ischaemia in end-stage renal disease. Clin Sci (Lond) (2007) 0.81
The contribution of statistical parametric mapping in the assessment of precuneal and medial temporal lobe perfusion by 99mTc-HMPAO SPECT in mild Alzheimer's and Lewy body dementia. Nucl Med Commun (2005) 0.80
The diagnostic and prognostic value of tissue Doppler imaging during dobutamine stress echocardiography in end-stage renal disease. Coron Artery Dis (2009) 0.79
A computer model of lung morphology to analyze SPECT images. Comput Med Imaging Graph (2002) 0.79
Preferred retinal locus profile during prolonged fixation attempts. Can J Ophthalmol (2013) 0.78
Analytical technique to recover the third dimension in planar imaging of inhaled aerosols: (1) impact on spatial quantification. J Aerosol Med (2006) 0.78
Generation of realistic HMPAO SPECT images using a subresolution sandwich phantom. Neuroimage (2013) 0.78
An analytical technique to recover the third dimension in planar imaging of inhaled aerosols--2 estimation of the deposition per airway generation. J Aerosol Med (2007) 0.76
Comment on Mertens et al.: Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases. Eur J Nucl Med Mol Imaging (2013) 0.75
Standardization of LVEF values from MUGA scanning. Nucl Med Commun (2008) 0.75
UK audit of analysis of quantitative parameters from renography data generated using a physical phantom. Nucl Med Commun (2014) 0.75
Probable range for whole kidney mean transit time values determined by reexamination of UK audit studies. Nucl Med Commun (2008) 0.75
Computer reconstruction of a human lung boundary model from magnetic resonance images. Respir Care (2004) 0.75
A technique for the simulation of planar radionuclide images of the kidney. Nucl Med Commun (2007) 0.75
UK audit of glomerular filtration rate measurement in 2001. Nucl Med Commun (2008) 0.75
Predicting the outcome of Legg-Calve-Perthes' disease in children under 6 years old. J Child Orthop (2007) 0.75
(99m)Tc-DTPA volume of distribution, half-life and glomerular filtration rate in normal adults. Nucl Med Commun (2013) 0.75
Optimization of the parameters of a method for computer-aided detection of perfusion deficiencies in brain images. Nucl Med Commun (2009) 0.75